                         SEQUENCE LISTING

<110>  The Salk Institute for Biological Studies
       Rothlin, Carla V.
       Lemke, Greg E.
 
<120>  USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM 
       ACTIVATORS AS IMMUNOSUPPRESSORS

<130>  7158-78567-03

<150>  60/986,984
<151>  2007-11-09

<150>  61/013,598
<151>  2007-12-13

<150>  61/083,462
<151>  2008-07-24

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for actin.

<400>  1
ctcctcctga gcgcaagtac tctgtgt                                           27


<210>  2
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for actin.

<400>  2
gtgcacgatg gaggggccgg actcat                                            26


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for AXL.

<400>  3
atgccagtca agtggattgc t                                                 21


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for AXL.

<400>  4
cacacatcgc tcttgctggt                                                   20


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for BAFF .

<400>  5
tgctatgggt catgtcatcc a                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for BAFF .

<400>  6
ggcagtgttt tgggcatatt c                                                 21


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for GAPDH.

<400>  7
tcccactctt ccaccttcga                                                   20


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for GAPDH.

<400>  8
agttgggata gggcctctct t                                                 21


<210>  9
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer IFN beta.

<400>  9
atgagtggtg gttgcaggc                                                    19


<210>  10
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer IFN beta.

<400>  10
tgacctttca aatgcagtag attca                                             25


<210>  11
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer IRAK-M.

<400>  11
agccagtctg aggtcacctt tc                                                22


<210>  12
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer  IRAK-M.

<400>  12
cgttgcaatc cgcttcact                                                    19


<210>  13
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for SHIP.

<400>  13
accagcatga catttaaaac agttg                                             25


<210>  14
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for SHIP.

<400>  14
agatatggct gatccgattc tca                                               23


<210>  15
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for SOCS1.

<400>  15
ccgtgggtcg cgagaac                                                      17


<210>  16
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for SOCS1.

<400>  16
aactcaggta gtcacggagt accg                                              24


<210>  17
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer for SOCS3.

<400>  17
tcccatgccg ctcacag                                                      17


<210>  18
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer foir SOCS3.

<400>  18
acaggaccag ttccaggtaa ttg                                               23


<210>  19
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide CpG-ODN 1668

<400>  19
tccatgacgt tccgatgct                                                    19


<210>  20
<211>  53
<212>  PRT
<213>  Homo sapiens

<400>  20

Gln Phe Leu Arg Pro Arg Gln Arg Arg Ala Phe Gln Val Phe Glu Glu 
1               5                   10                  15      


Ala Lys Gln Gly His Leu Glu Arg Glu Cys Val Glu Glu Leu Cys Ser 
            20                  25                  30          


Arg Glu Glu Ala Arg Glu Val Phe Glu Asn Asp Pro Glu Thr Asp Tyr 
        35                  40                  45              


Phe Tyr Pro Arg Tyr 
    50              


<210>  21
<211>  60
<212>  PRT
<213>  Homo sapiens

<400>  21

Glu Ala Asn Leu Leu Ser Lys Gln Gln Ala Ser Gln Val Leu Val Arg 
1               5                   10                  15      


Lys Arg Arg Ala Asn Ser Leu Leu Glu Glu Thr Lys Gln Gly Asn Leu 
            20                  25                  30          


Glu Arg Glu Cys Ile Glu Glu Leu Cys Asn Lys Glu Glu Ala Arg Glu 
        35                  40                  45              


Val Phe Glu Asn Asp Pro Glu Thr Asp Tyr Phe Tyr 
    50                  55                  60  


